Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial

Journal:

Thorax

Published:

2025-12-16

DOI:

10.1136/thorax-2025-223282

Affiliations:

9

Authors:

8

Go to article

Institutions	Authors	Share
The University of Manchester (UoM), United Kingdom (UK)	2.833333	0.35
Copenhagen University Hospital (CUH), Denmark	1.500000	0.19
Manchester Academic Health Science Centre (MAHSC), United Kingdom (UK)	1.333333	0.17
University of Copenhagen (UCPH), Denmark	1.000000	0.13
Northern Care Alliance NHS Foundation Trust, United Kingdom (UK)	1.000000	0.13
IQVIA United Kingdom, United Kingdom (UK)	0.333333	0.04

Interested in Cardiovascular Medicine and Haematology?